Why Primary Health Care Limited (ASX:PRY) shares crashed lower today

The Primary Health Care Limited (ASX: PRY) share price has been one of the worst performers on the local market on Thursday.

At the time of writing the healthcare company’s shares are down a sizeable 10% to $3.48, wiping out all the gains that they had made in 2018.

Why are Primary Health Care shares plunging lower?

With no news out of Primary Health Care this morning, today’s decline is likely to be attributable to a broker note out of UBS.

According to the note, the broker has downgraded the company’s shares all the way down from a buy rating to a sell rating. UBS has also cut the price target on the company’s shares to a lowly $3.50 from $4.00.

The sudden change in opinion is largely down to the broker changing the analyst covering the company.

The new analyst has adjusted the broker’s valuation after reducing its earnings forecasts by as much as 9% for FY 2019 and FY 2020.

In addition to this, the broker didn’t believe that the share price had factored in the risks to its earnings next year.

Should you buy the dip?

Based on the broker’s forecasts, Primary Health Care’s shares are now changing hands at just over 19x full-year earnings and around 18.5x estimated FY 2019 earnings.

Given its challenging growth profile, I don’t believe this represents value for money even after today’s sizeable decline.

As such, I would put Primary Health Care with both Ramsay Health Care Limited (ASX: RHC) and Healthscope Ltd (ASX: HSO) as healthcare shares to avoid right now.

Instead, I would suggest that investors focus their attention on healthcare shares which are exhibiting strong growth such as Cochlear Limited (ASX: COH) and ResMed Inc (ASX: RMD). While both trade at a premium to the market average, I believe their medium term growth prospects more than justify this.

Alternatively, these mid cap star stocks could be even better options for investors.

The Disruptors: 3 Revolutionary Aussie Companies to Back in FY 2019

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.